The Application of a Three-Step Serum Proteome Analysis for the Discovery and Identification of Novel Biomarkers of Hepatocellular Carcinoma

Table 2

Clinical characteristics of 64 patients with HCC, 60 with LC and 60 normal control subjects.

	HCC	LC	Normal control
	𝑛=64	𝑛=60	𝑛=60
Age, mean ± SD	66.1±9.9	56.8±12.3	54.5±7.0
Male/female	7.0	6.5	6.5
AFP level (ng/mL), mean ± SD	1926.2±11904.7	14.7±24.2	3.5±1.6
PIVKA-II level (mAu/mL), mean ± SD	11757.2±50071.5	18.1±12.5	19.71±5.4